EMUC23 tackles current challenges of PSMA PET/CT in PCa
November 2, 2023Read morePlenary Session 5 “Nuclear medicine in urology: Lessons learnt and new horizons” of the EAU Section of Urological Imaging (ESUI)...
00
ESUP: A review of biomarkers and molecular tests in bladder urothelial carcinoma
November 2, 2023Read moreThe Uropathology Symposium of the EAU Section of Uropathology (ESUP) delivered the latest updates on biomarkers and molecular tests...
ESUI meeting examines novel imaging trials
November 2, 2023Read moreToday, Plenary Session 3 of the EAU Section of Urological Imaging (ESUI) meeting examined the latest evidence in three...
ESUI: Getting ready for the new EU approach to PCa screening
November 2, 2023Read moreThis year, the annual EAU Section of Urological Imaging (ESUI) meeting has been integrated into the 15th European Multidisciplinary...
EMUC23: GU cancer game-changers for 2023
September 14, 2023Read moreA collaborative approach to reviewing trials prevents tunnel vision Collaborative efforts are required to drive game-changing advancements in medical...
Adverse events: Cornerstone for safer pathways?
August 14, 2023Read moreLearning points from morbidity and mortality Adverse events can positively transform new approaches in patient management. How? By applying...
Synergy of specialties at EMUC23: Why MDTs are paramount to optimal patient care
June 7, 2023Read moreThroughout the years, the European Multidisciplinary Congress on Urological Cancers (EMUC) has garnered a loyal following and a steady growth...
AI opportunities in GU Cancers
November 12, 2022Read moreLooking to the future, Prof. Arnulf Stenzl (DE), Prof. Alberto Briganti (IT) and Dr. Bob Schijvenaars (NL) chaired the...
New trial results for PEACE-1, OpeRa, and adjuvant therapies in high-risk RCC
November 12, 2022Read moreA selection of new trial results were shared and discussed in Plenary Session 5 on day three of EMUC22....
